> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Rare Disease Clinical Trial Resource Center Proposed
- URL: https://www.fdaweb.com/rare-disease-clinical-trial-resource-center-proposed/
- Published: 2020-08-06T12:00:00.000Z
- Updated: 2026-09-14T16:24:11.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147371

The Rare Disease Clinical Trial Network (RDCRN) funded by the National Institute of Health says there is a need for a Rare Disease Clinical Trial Resource Center that could be leveraged by existing research networks or consortia doing global clinical research in rare diseases. The [recommendation](https://beta.regulations.gov/document/FDA-2020-N-0837-0050?ref=fdaweb.com) is part of the RDCRN response to an FDA request for information and comments on rare disease clinical trial networks.

The RDCRN says it is a research network of 20 rare disease clinical research consortia that are each focused on at least three related rare disorders. It says the intent in establishing a Rare Disease Clinical Trials Resource Center would be to develop a center of excellence to serve as a resource for existing rare disease networks and consortia that will provide the expertise required to design and execute a development program for a new drug, medical device, or biologic that drives efficiency, reduces timelines, and increases the probability of success for getting more treatments to market for rare diseases.